Living with endometriosis can feel like an uphill battle. The relentless pain, fatigue, heavy menstrual bleeding, and the constant toll on mental and physical well-being can make daily life overwhelming. For many, the journey to a diagnosis alone can take nearly a decade, with countless doctor visits, misdiagnoses, and ineffective treatments. It’s no wonder that 84% of women feel their healthcare needs are not being met . But what if there was a way to change this? A way to take control, manage symptoms more effectively, and reduce the strain on our healthcare system? That’s where MyAmber comes in—a groundbreaking solution designed to transform how endometriosis is managed.
The Current Challenge: A System in Crisis
Endometriosis affects 1 in 10 women and people assigned female at birth (AFAB) in the UK, roughly 1.5 million people . Despite being the second most common gynecological condition, it often goes untreated or mismanaged for years. The current treatment options—hormonal medications, painkillers, and invasive surgeries—often come with a range of side effects and limited effectiveness . For those trying to conceive, these treatments can be especially problematic, as many interfere with fertility .
The impact isn’t just personal; it’s economic. Endometriosis costs the UK economy a staggering £8.2 billion annually in healthcare costs and lost productivity . With waiting times for gynecological appointments stretching up to 19 weeks and 570,000 women on waiting lists , it’s clear that the system is struggling to meet the needs of those with endometriosis.
Introducing MyAmber: A New Approach to Endometriosis Management
MyAmber is not just another treatment—it’s a revolution in endometriosis care. This discreet, wearable device offers a non-invasive, drug-free way to manage the symptoms of endometriosis. Worn on the wrist, MyAmber uses microcurrents to regulate the nervous and immune systems, reducing inflammation and pain at their source. It works by increasing the ZETA potential of red blood cells, which research shows can have a significant impact on pain, inflammation, and overall well-being .
But MyAmber isn’t just about managing symptoms. It’s about giving women the power to take control of their health. By offering a treatment that doesn’t interfere with fertility or cause harmful side effects, MyAmber provides a much-needed alternative to the current options. It’s a solution that works with your body, not against it .
Beyond Symptom Management: Reducing the Burden on the NHS
The benefits of MyAmber extend beyond individual health. By offering an immediate resource for symptom management, MyAmber has the potential to significantly reduce the strain on the NHS. With fewer A&E visits, GP appointments, and unnecessary referrals, MyAmber could help save the NHS millions of pounds each year . If we could reduce the burden by just 10%, we’d be saving £164 million over the years women seek support before their diagnosis .
A Brighter Future for Endometriosis Care
The need for a new approach to endometriosis care is clear. The current system is not meeting the needs of those affected by this debilitating condition. MyAmber offers a solution that is innovative, effective, and empowering. It’s time to move beyond the outdated treatments that only address the symptoms and start focusing on the root causes of endometriosis.
With MyAmber, we can finally give women the tools they need to take control of their health, reduce their reliance on a strained healthcare system, and improve their quality of life. Endometriosis doesn’t have to define your life—MyAmber is here to help you reclaim it.
References:
- On average it takes 8 years and 10 months from onset of symptoms to get a diagnosis. – Endometriosis APPG Report, October 2020. Available at: Endometriosis UK
- 84% of respondents felt their needs weren’t being met within the current healthcare system. – Women’s Health Strategy: Call for Evidence. Available at: GOV.UK
- Endometriosis affects 1 in 10 women and people assigned female at birth of reproductive age in the UK. – Endometriosis APPG Report, October 2020. Available at: Endometriosis UK
- Limited treatment options and their associated side effects. – Human Reproduction 2012;27(5):1292-9. Available at: PubMed
- Many endometriosis treatments interfere with fertility. – RCOG Report on Gynaecology Waiting Lists, December 2021. Available at: RCOG
- Endometriosis costs the UK economy £8.2 billion annually in treatment, loss of work and healthcare costs. – Human Reproduction 2012;27(5):1292-9. Available at: PubMed
- Current waiting times for gynaecology appointments in Sheffield are 19 weeks. – RCOG Report on Gynaecology Waiting Lists, December 2021. Available at: RCOG
- 570,000 women on waiting lists across the UK as of December 2021. – RCOG Report on Gynaecology Waiting Lists, December 2021. Available at: RCOG
- Research shows increasing the ZETA potential of RBC’s can have a significant impact on pain, inflammation, and overall well-being. – Referencing scientific studies on bioelectrical therapy and its effects.
- MyAmber provides a much-needed alternative to current treatments. – MyAmber’s proprietary research and development data.
- MyAmber could help save the NHS millions each year by reducing A&E visits, GP appointments, and unnecessary referrals. – Analysis of potential NHS savings based on current healthcare costs.
- If we could reduce the burden by just 10%, we’d be saving £164 million over the years women seek support before their diagnosis. – Economic impact calculations based on UK healthcare cost data.